Exploring healthcare workers’ perceptions and experiences regarding post-traumatic stress disorder after 2 years of the last global pandemic.

Publication date: Jul 01, 2025

The adverse mental health consequences of the coronavirus epidemic for healthcare workers (HCWs) affect the quality of care and patient satisfaction; HCWs need to maintain good mental health during and after an epidemic, especially in low-income countries like Iran, where human resources in the health care sector are insufficient. The aims of this study are to explore the perceptions and experiences of healthcare workers regarding post-traumatic stress disorder (PTSD) after 2 years of the last Global Pandemic. We conducted the present study in Mazandarn province, Iran, using a qualitative approach based on conventional content analysis. Participants were Iranian healthcare workers (HCWs) aged 30 and above, all with a history of post-traumatic stress disorder (PTSD) symptoms. Eligible candidates were selected through both purposive sampling (with maximum variation) and snowball sampling to ensure diversity in demographic characteristics and lived experience of phenomena. Data were collected through in-depth, semi-structured interviews, continuing until data saturation was reached. The interviews were analyzed using MAXQDA10 software, following the conventional content analysis approach as outlined by Graneheim and Lundman. Our analysis yielded five main themes and 18 categories: [1] Helplessness, including six categories: physical consequences, psychological reactions, feeling of guilt, job-related consequences, social consequences, and lack of support; [2] poor risk management, encompassing four categories: inadequate vocational skills training, poor anger management, low sense of security, and hazardous work environments; [3] life and death experience, with two categories: hopelessness about life and the future, and witnessing unexpected deaths; [4] seeking support, comprising three categories: social support, psychological support, and organizational support, and [5] self-care, involving three categories: personal responsibility for health, maintaining a healthy lifestyle, and building resilience against PTSD. Our findings reveal a concerning picture of the mental health status of Iranian HCWs, particularly regarding the impact of the most recent pandemic. Many participants reported significant symptoms of stress, depression, anxiety, and PTSD, all of which profoundly affect their overall well-being. The most prominent themes identified were feelings of helplessness, inadequate risk management, encounters with life-and-death situations, and insufficient support systems. Alarmingly, several HCWs expressed intentions to leave their current positions or exit the healthcare profession altogether. Such trends pose a serious threat to the stability of Iran’s healthcare system. Consequently, proactive, solution-oriented strategies must be developed-both at the national level and in collaboration with international stakeholders-to mitigate the ongoing healthcare workforce shortage in Iran and address the broader global risk of healthcare service disruption.

Open Access PDF

Concepts Keywords
Coronavirus Adult
Healthcare COVID-19
Iran Female
Poor Health Personnel
Snowball Healthcare workers
Humans
Interviews as Topic
Iran
Male
Middle Aged
Pandemic
Pandemics
PTSD
Qualitative
Qualitative Research
SARS-CoV-2
Stress Disorders, Post-Traumatic

Semantics

Type Source Name
disease MESH post-traumatic stress disorder
disease IDO quality
disease IDO history
disease MESH death
disease MESH lifestyle
disease MESH health status
disease MESH depression
disease MESH anxiety
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH syndrome
disease MESH COVID 19
disease MESH infection
drug DRUGBANK Etoperidone
disease MESH insomnia
disease MESH confusion
disease MESH psychological well being
disease MESH mental disorders
disease MESH burnout
disease IDO process
drug DRUGBANK Methionine
drug DRUGBANK L-Phenylalanine
drug DRUGBANK Indoleacetic acid
disease IDO role
disease MESH chronic pain
disease MESH cancer
disease MESH epilepsy
drug DRUGBANK Creatinolfosfate
disease MESH facial expressions
drug DRUGBANK Trestolone
disease MESH sleep quality
drug DRUGBANK Ethanol
disease MESH sleep disorder
disease MESH restlessness
disease MESH compulsive behaviors
disease MESH panic
drug DRUGBANK Isoxaflutole
disease MESH retirement
disease MESH Social stigma
disease MESH Uncertainty
disease MESH physical attacks
disease MESH bullying
disease MESH Shock
disease MESH Sudden death
disease MESH mental fatigue
disease MESH loneliness
disease MESH Psychological stress
disease MESH critically ill
disease MESH impulsive behaviors
disease MESH infectious diseases
drug DRUGBANK Dimercaprol
drug DRUGBANK Diethylstilbestrol
disease MESH emotional distress
drug DRUGBANK Tropicamide
drug DRUGBANK Medical air
disease MESH cognitive impairments
disease MESH obsessive behaviors
disease MESH suicidal ideation
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH living alone
disease MESH emotional disturbances
disease MESH workplace stress
disease MESH personality disorders
disease MESH infection transmission
disease MESH emergency
drug DRUGBANK (S)-Des-Me-Ampa
disease IDO symptom
disease MESH Prolonged Grief Disorder
disease MESH emotional fatigue
pathway REACTOME Immune System
disease MESH neuroticism
disease IDO intervention
drug DRUGBANK Carboxyamidotriazole
disease MESH occupational burnout
drug DRUGBANK Nonoxynol-9
disease MESH Morbidity
disease MESH severe acute respiratory syndrome
disease MESH suicide
disease MESH panic disorder
disease MESH influenza
disease MESH AIDS
disease MESH STDs
disease MESH HIV infection
pathway REACTOME HIV Infection
drug DRUGBANK Guanosine
disease MESH coronavirus infection
disease MESH Comorbidity
disease MESH perinatal death
disease MESH anxiety disorders
drug DRUGBANK Imipramine

Original Article

(Visited 10 times, 1 visits today)